News
Synhale has acquired telaglenastat, and is planning a Phase 2 clinical trial testing the therapy in patients with pulmonary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback